FDA Inspection
Nana Barseghian, M.D.Nana Barseghian, M.D. – FDA Inspection, Feb 16, 2024
Record Details
This FDA Inspection record concerns Nana Barseghian, M.D., with an inspection on February 16, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e3ab1667-5be8-40a4-9c73-0fbf567cd1a5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1230233
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.60Informed consent
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.